ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011

Robert Cook-Deegan On Implications of Appelate Court Ruling In Myriad Case Ruling

August 5, 2011

NCI program announcement available, contract awards listed.

November 14, 2003

Bishop: Cells, Genes Reveal Unified Strategy For Cancer Conquest

March 3, 1995

Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows

March 30, 2012

SEER Program Challenged, Will Face Review

May 9, 1980